Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

27
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

31
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

489
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
489
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

21
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
21
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

367
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
367
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

462
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
462

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Mediating Role of Sleep Problems in the Association Between Attention-Deficit/Hyperactivity Disorder and Self-Injurious Thoughts and Behaviors in Children Aged 9-12 in the United States.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2025
Same author

A shared hippocampal hub for anxiety and memory contrasts with depression-specific circuitry: A high-resolution 7T fMRI study.

Journal of affective disorders·2025
Same author

Demographic, genetic, neuroimaging, and behavioral correlates of short social responsiveness scale in a large pediatric cohort.

Translational psychiatry·2025
Same author

Association of Remnant Cholesterol with Rapid Kidney Function Decline in Middle-Aged and Older Adults with Normal Kidney Function.

Kidney diseases (Basel, Switzerland)·2025
Same author

Integrating metagenomics, lipidomics and proteomics to explore the effect and mechanism of ginsenoside Rb1 on atherosclerosis co-depression disease.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2025
Same author

Comprehensive metagenomic and lipidomic analysis showed that baicalin could improve depressive behaviour in atherosclerotic mice by inhibiting nerve cell ferroptosis.

Frontiers in immunology·2025

Related Experiment Video

Updated: Aug 29, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.1K

Vitamin D and heart failure: A two-sample mendelian randomization study.

Qiang Luo1, Wei Yan1, Qiong Nie1

  • 1Department of Cardiology, Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, 82 Qinglong St. Chengdu, Sichuan, China.

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|September 5, 2022
PubMed
Summary
This summary is machine-generated.

Low vitamin D levels (25-hydroxyvitamin D) are linked to increased heart failure (HF) risk. Maintaining adequate vitamin D may help prevent heart failure.

Keywords:
Causal inferenceHeart failureMendelian randomizationVitamin D

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

201
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Related Experiment Videos

Last Updated: Aug 29, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.1K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

201
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Nutritional Science

Background:

  • The link between vitamin D and heart failure (HF) is of significant interest but remains uncertain.
  • Previous studies have yielded conflicting results regarding this association.

Purpose of the Study:

  • To investigate the potential causal relationship between 25-hydroxyvitamin D (25OHD) levels and the risk of heart failure (HF).
  • To provide reliable evidence on the association between vitamin D status and HF risk using advanced statistical methods.

Main Methods:

  • Employed two-sample Mendelian randomization (MR) using large-scale genome-wide association study summary statistics for 25OHD and HF.
  • Utilized multiple MR methods and multivariable MR adjusting for key comorbidities (hypertension, BMI, diabetes, CKD).
  • Performed MR analysis with conditionally independent genetic instruments to address potential pleiotropy.

Main Results:

  • A significant inverse association was found: a 1 SD increase in 25OHD was associated with a 16.5% decreased risk of HF (OR: 0.835, P=0.002).
  • Consistent results were observed across various MR analyses, including multivariable MR.
  • Scatter plots indicated a trend towards an inverse association between 25OHD levels and HF risk.

Conclusions:

  • Elevated 25-hydroxyvitamin D levels are potentially inversely associated with heart failure risk.
  • Maintaining adequate vitamin D status may be a crucial strategy for preventing heart failure in the general population.